← Back
$KROS All transactions

Keros Therapeutics, Inc.

A

$ Value

$0

Shares

90,500

Price

$0

Filed

Sep 5

Insider

Name

Seehra Jasbir

Title

CHIEF EXECUTIVE OFFICER

CIK

0001732369

Roles

Director Officer

Transaction Details

Transaction Date

2025-09-03

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

392,723

Footnotes

Represents a restricted stock unit ("RSU") award. The RSUs vest as follows: 25% of the RSUs shall vest on each of February 18, 2026, February 18, 2027, February 18, 2028 and February 18, 2029, in each case, subject to the Reporting Person continuing to provide service through each such date.

Filing Info

Accession No.

0001415889-25-023791

Form Type

4

Issuer CIK

0001664710

Seehra Jasbir's History

Date Ticker Type Value
2026-04-02 KROS M $16K
2026-04-02 KROS M $0
2025-09-03 KROS A $0

Other Insiders at KROS (90d)

Insider Bought Sold Last
BIENAIME JEAN JACQUES $12K 2026-04-15
Seehra Jasbir
CHIEF EXECUTIVE OFFICER
2026-04-02
Cho Esther
Chief Legal Officer
2026-02-24